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ABSTRACT
Alternative splicing events that are conserved in
orthologousgenesindifferentspeciesarecommonly
viewed as reliable evidence of authentic, functionally
significant alternative splicing events. Several
recent bioinformatic analyses have shown that con-
served alternative exons possess several features
that distinguish them from alternative exons that
are species-specific. One of the most striking differ-
ences between conserved and species-specific
alternative exons is the high percentage of exons
that preserve the reading frame (exons whose
length is an exact multiple of 3, termed symmetrical
exons) among the conserved alternative exons.
Here, we examined conserved alternative exons and
found several features that differentiate between
symmetrical and non-symmetrical alternative
exons. We show that symmetrical alternative exons
have a strong tendency not to disrupt protein
domain structures, whereas the tendency of non-
symmetrical alternative exons to overlap with
different fractions of protein domains is similar to
that of constitutive exons. Additionally, skipping
isoforms of non-symmetrical alternative exons
are strongly underrepresented, compared with
their including isoforms, suggesting that skipping
of a large fraction of non-symmetrical alternative
exons produces transcripts that are degraded
by the nonsense-mediated mRNA decay mechanism.
Non-symmetrical alternative exons also show a
tendency to reside in the 50 half of the CDS. These
findings suggest that alternative splicing of symmet-
rical and non-symmetrical exons is governed by
different selective pressures and serves different
purposes.
INTRODUCTION
Alternative splicing creates multiple mRNA products from a
single gene. This mechanism is widespread in higher euka-
ryotes: bioinformatic analyses indicate that more than half of
human genes undergo alternative splicing (1,2). As the estim-
ated number of human proteins ( 90000) far exceeds the
number of known protein-coding genes ( 26000), alternative
splicing was suggested as the key mechanism for bridging this
numerical disparity (3–5). The ability of alternative splicing to
greatly increase the protein-coding capability of a single gene
is well demonstrated in the Drosophila’s Dscam gene, which
has the potential capability to generate up to 38016 distinct
protein isoforms by means of combinatorial alternative
splicing of multiple ‘exon cassettes’ (6).
In many cases, alternative splicing creates protein isoforms,
either with partially or completely different functionality from
a single gene, by selectively inserting or removing protein
domains encoded by alternative ‘cassette’ exons (i.e. altern-
ative exons of the exon-skipping type: they are either com-
pletely included or completely removed from the mRNA
product). Some examples of domain architecture alternations
caused by alternative splicing are the removal of signal pep-
tides and transmembrane regions, which affects protein loc-
alization (7); the insertion of different structural elements to
ion-channel genes in different nervous system cells (8,9) and
the removal of ethylene receptors in peaches, which affects the
fruit’s ripening time (10).
In addition to its role in increasing proteome diversity,
alternative splicing is also known to produce splice forms
that are not being translated into proteins, but, rather, play
a regulatory role. The best-described example for such ‘unpro-
ductive’ splicing is the generation of splice variants targeted
for degradation by the nonsense-mediated mRNA decay
mechanism (NMD) (1,11–13). NMD is an RNA surveillance
function that recognizes mRNAs containing premature termi-
nation codons (PTCs) and targets them for degradation, rather
than translation into proteins [reviewed in (14)]. It was even
suggested that as much as 35% of human alternative isoforms
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+ mRNAs) (15). This widespread
coupling of NMD and alternative splicing suggests that
NMD-targeted transcripts play an important regulatory role,
probably in the downregulation of gene expression (1,11,15).
However, for the vast majority of alternative splicing events
predicted from bioinformatic analyses, which are predomin-
ately based on expressed sequence tag (EST) data, the func-
tional signiﬁcance is unknown (4,16,17). Moreover, as a large
fraction of ESTs in dbEST comes from cancer-related tissues,
many of these alternative splicing events might represent
aberrant splicing or EST artifacts (18–20). In this study, we
examined a dataset of alternatively spliced cassette exons that
are conserved between human and mouse. The conservation
of these alternative exons in both species, which diverged
from their common ancestor 75–130 million years ago, sug-
geststhattheseexon-skippingeventsrepresenttrulyfunctional
splicing events (19,21).
It has been previously reported that alternative cassette
exonsthatareconservedinseveralspeciespossesssomeunique
features that distinguish them from species-speciﬁc exons
(i.e. alternative exons that exist in a human gene, but not in
its mouse counterpart or vice versa). Compared with species-
speciﬁc exons, conserved exons tend (i) to be shorter (19);
(ii) to have a high inclusion level (i.e. the number of ESTs/
mRNAsthatrepresenttheirinclusionishigherthanthenumber
of those that skip them) (22); (iii) not to contain repetitive
elements (19) and (iv) to be in a length that is divisible by 3
[termed ‘symmetrical exons’, see also (23)], if they reside
within the protein coding region (CDS) (19,24–26). The high
percentage of symmetrical exons among conserved alternative
exons within the CDS (53–77%, with respect to an expected
percentage of 33% without any bias for divisibility by 3)
reﬂects a functional pressure for preserving protein coding,
as insertion or skipping of these exons does not alter the
reading frame (21,25), whereas alternative splicing of non-
symmetrical exons always induces a frameshift (Figure 1).
Constitutive exons were also found to have a bias toward
being symmetrical, but this bias is much more moderate
( 40% are symmetrical) (23,25,27).
In this study, we examined the differences between sym-
metrical and non-symmetrical conserved alternative exons
with respect to several characteristics. We found that they
differ (i) in their tendency to overlap with coding sequences
for protein domains, (ii) in their inclusion level, (iii) in the
coverage of their skipping isoforms in GenBank and (iv) in
their preference for speciﬁc locations along the CDS. These
ﬁndings suggest that symmetrical and non-symmetrical con-
served alternative exons are under different selective pressures
and may play different functional roles, such as NMD activa-
tion by skipping of non-symmetrical alternative exons.
MATERIALS AND METHODS
Database compilation
We used two databases in our analysis: one of conserved
alternative exons (only cassette exons) and one of con-
served constitutive exons. The conserved alternative exons
consisted of 823 human exons, 664 mouse exons, 86 rat
exons and 22 dog exons, along with their corresponding
mRNAs from RefSeq, NCBI’s database of curated and
non-redundant reference sequences (http://www.ncbi.nlm.
nih.gov/RefSeq/) (28). The conserved constitutive exons data-
base consisted of 39720 human–mouse homologous constitu-
tive exons and their matching 6124 RefSeq mRNAs, already
compiled by us (http://www.tau.ac.il/~gilast/sup_mat2.htm)
(29).
Compilation of the alternative exons database was
performed in several stages: we started with a dataset of
human–mouse homologous alternative cassette exon pairs,
which was built by integrating three source databases:
(i) http://www.soe.ucsc.edu/~sugnet/psb2004/altGraphXCon.
html (30).
(ii) http://www.tau.ac.il/~gilast/sup_mat2.htm (29).
(iii) http://www.sciencedirect.com/science/MiamiMultiMedia
URL/B6TCY-4B9558H-1/B6TCY-4B9558H-1-C/5183/
f9bdffb6d98512adebc2e545a0151900/ Application_1.
xls (19).
We removed all duplications and remained with 1285 pairs
of human–mouse homologous alternative exons. As all three
source databases were compiled usingEST data, we blasted all
exons against RefSeq, NCBI’s database of curated and non-
redundant reference sequences (http://www.ncbi.nlm.nih.gov/
RefSeq/) (28), to ﬁnd their matching full-length mRNAs for
further analysis. We found such RefSeq mRNAs for 823
human exons and 664 mouse exons.
To ﬁnd rat conserved alternative cassette exons, we
searched NCBI’s HomoloGene database (www.ncbi.nlm.
Figure 1. Different impact on the reading frame of symmetrical and non-
symmetrical alternatively spliced exons. (A) A gene consisting of three exons
whose second exon is a symmetrical cassette exon (90 nt). Skipping and
inserting of the symmetrical exon does not alter the reading frame: the
sequence upstream and downstream to the alternative exon encodes for
the same peptide sequence in the including and skipping isoforms. (B) A gene
consistingofthreeexonswhosesecondexonisanon-symmetricalcassetteexon
(91 nt). Skipping of the non-symmetrical exon results in a frameshift down-
stream to the alternative exon.
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mRNAs that are homologous to the 823 human RefSeq
mRNAs in our dataset. For each pair of human and rat homo-
logous mRNAs, we aligned the human alternative exon and
the rat mRNA, using clustalW. This yielded 319 rat mRNAs
that include a sequence with >80% identity with the human
alternative exon incorporated in their human homologous
mRNA. We then wanted to verify that these sequences in
rat mRNAs are indeed alternative cassette exons. For that,
we ran two blast searches against dbEST: (i) of the putative
rat alternative exon and 50 nt on both sides (from its ﬂanking
exons), representing the exon-including isoform; and (ii) of
a concatenation of the ﬂanking 50 nt, representing the
exon-skipping isoform. We used only blast results with
E-value < 1 · 10
 4. If an EST was hit on both blasts, we per-
formed pairwise alignment both of the EST and the sequence
representing the exon-including isoform and of the EST and
the sequence representing the exon-skipping isoform, using
the clustalW algorithm. According to the clustalW score, we
determined whether the EST includes the exon or skips it.
This left us with 86 rat exons that have EST evidence showing
they incorporate an alternative cassette exon (which is con-
served in human). We repeated the same procedure with dog
exons and found 22 dog exons conserved in human and with
evidence for both their skipping and inclusion in dog.
Finding exon-skipping and exon-including isoforms
Detection of exon-skipping isoforms was conducted in the
same manner as the search for ESTs that provide evidence
for the skipping of rat and dog alternative exons (see above).
However, for this analysis, the blast was performed against
human and mouse GenBank mRNAs (rather than dbEST),
becausewesearched forfull-lengthmRNAswherethecassette
exons are skipped. GenBank mRNAs were downloaded from
the UCSC genome browser (http://hgdownload.cse.ucsc.edu/
downloads.html).
Inclusion level calculation
We calculated the inclusion level only for exons for which at
least one including and one skipping mRNA were found. The
inclusion level of an exon was determined as the quotient of
the numberofmRNAs representingitsexon-includingisoform
divided by the number of all mRNAs that include or skip
the exon.
Normalization of exon location within CDS
To normalize the exon location within the CDS, we ﬁrst cal-
culated N, which is the number of all possible locations for
the start point of this exon in the CDS without exceeding the
boundaries of the CDS (N ¼ CDS length   exon length + 1).
The normalized location was determined as the quotient of
the actual location of the exon’s start point within the CDS
divided by N.
Manual analysis of the effect on the reading frame of
a random sample of non-symmetrical and symmetrical
alternative exons
We usedthe mRNA/genomicalignments inthe UCSC genome
browser to manually compare between exon-skipping and
exon-including mRNAs. We ﬁrst blasted each mRNA against
the genome, at http://genome.ucsc.edu/cgi-bin/hgGateway.
Then we followed the link to the mRNA information and
examined its mRNA/genomic alignment to determine its
CDS boundaries and exon–intron junctions. This allowed us
to determine the differences between the two isoforms in the
CDS level (i.e. if they use different start and stop codons, if a
frameshift occurs, etc.). All the CDS annotations we used are
based on SWISS-PROT, TrEMBL, mRNA and RefSeq.
Statistical analysis
We used two statistical tests in this work: t-test and Fisher’s
exact test. t-test could be applied due to large sample size. For
all statistical analyses, the level of statistical signiﬁcance was
ﬁxed at 0.01.
RESULTS
To analyze conserved alternative splicing events, we compiled
a dataset of 823 human alternative cassette exons (only exons
for which the mouse homolog is alternatively spliced as well).
Of these exons, 91.3% (751/823) are located within the CDS
(CDS-internal exons). The rest either reside in the 50 or 30
untranslated regions (UTRs) (2.2%—18/823 and 0.4%—3/
823, respectively) or contain the start or the stop codon
(2.8%—23/823 and 3.4%—28/823, respectively). For each
exon, we found a matching mRNAin NCBI’s RefSeq database
(see Materials and Methods). As a control, we repeated all
analyses on a dataset of 39720 human constitutively spliced
exons (only exons for which the mouse homolog is con-
stitutively spliced as well) and their matching 3062 RefSeq
mRNAs, which was compiled by us previously (29). Analyses
were repeated with a dataset of conserved alternatively spliced
and constitutively spliced mouse exons, as well as with a
dataset of conserved alternatively spliced exons of rat and
dog. The results of these analyses are in correlation with
the results obtained from analyzing the human exons dataset
(see Supplementary Data).
We ﬁrst conﬁrmed that the CDS-internal alternative exons
in our dataset are biased to be symmetrical. Indeed, 68.6%
(515/751) were found to be symmetrical. As expected, the
alternative exons that are not CDS-internal exhibit a much
milder bias to be symmetrical (41.6%—30/72, are symmet-
rical), as do the CDS-internal constitutive exons (39.7%—
15608/39253).
Percentage of symmetrical alternative exons that
overlap with protein domains is low compared
with non-symmetrical ones
We compared symmetrical and non-symmetrical alternative
exons with respect to their potential to insert or remove
protein domains. For that, we searched against Pfam and
Smart databases (31,32) for protein domains in the mRNAs
of the 751 alternative and 39253 constitutive exons that are
CDS-internal, and compared the percentage of symmetrical
and non-symmetrical exons that overlap with domains (i.e.
encode for a fragment of domain or possess the full extent
of a coding sequence of a domain).
We found that the percentage of symmetrical alternative
exons that overlap with protein domains is signiﬁcantly
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constitutive exons. As shown in Figure 2, 30.3% (156/515) of
symmetrical alternative exons overlap with domains, com-
pared with 53% (126/236) of non-symmetrical alternat-
ive exons, P < 9 · 10
 10 (Fisher’s exact test). With respect
to constitutive exons, 54% (8433/15608) of symmetrical
exons and 54.3% (12850/23645) of non-symmetrical exons
overlap with coding sequences for protein domains. The
differences between symmetrical and non-symmetrical
constitutive exons and between non-symmetrical alternative
exons and all constitutive exons are not statistically signiﬁcant
(P > 0.2 in all cases).
It has been previously shown that conserved alternative
exons tend to be shorter than conserved constitutive exons
(33). Therefore, the bias of symmetrical alternative exons
against overlapping with protein domains could potentially
stem from their relative short length. We found that the aver-
age length of symmetrical alternative exons is indeed slightly
shorter than that of non-symmetrical ones: 113.3 and 116.9 nt,
respectively, but this difference is not statistically signiﬁcant
(P < 0.6, t-test). Moreover, among constitutive exons, sym-
metrical exons are also shorter than non-symmetrical ones:
128.4 and 131.2 nt, respectively, and this difference does
reach statistical signiﬁcance (P < 0.01). Therefore, the slight
difference in the average length of symmetrical and non-
symmetrical alternative exons cannot account for the tendency
of symmetrical alternative exons not to overlap with protein
domains.
Symmetrical alternative exons tend not to overlap with
medium-sized fragments of protein domains
To further analyze the tendency of symmetrical alternative
exons not to overlap with protein domains, we compared
the percentage of symmetrical and non-symmetrical alternat-
ive and constitutive exons that encode different fractions of
domains, in increments of 10% (Figure 3A). Among alternat-
ive exons, we found that symmetrical exons are underrepres-
ented among exons that overlap with domain fragments
consisting of >10% and <60% of domains (which we term
medium-sized fragments). Among constitutive exons, the dif-
ferences between symmetrical and non-symmetrical exons
reach a statistical signiﬁcance only among exons that encode
complete domains (rather than only a fraction). This ﬁnding is
in correlation with previous studies, which showed that most
exons (constitutive and alternative) that hold complete protein
domains are symmetrical (23,27). Symmetrical alternative
exons also show a higher tendency to encode complete
domains compared with non-symmetrical ones, but this result
does not reach statistical signiﬁcance.
Our analysis is summarized in Figure 3B–E. It shows
that only symmetrical alternative exons tend not to encode
medium-sized fragments of domains (Figure 3B compared
with Figure 3C–E). Therefore, the low percentage of altern-
ative symmetricalexons that encode proteindomainfragments
or complete domains stems from the tendency of these exons
not to encode medium-sized fragments of domains. The
pattern of encoding different fractions of domains is similar
between non-symmetrical alternative exons and all constitu-
tive exons (symmetrical or non-symmetrical).
Skipping isoforms of non-symmetrical alternative
exons have a low representation in GenBank
Inclusion or skipping of a non-symmetrical alternative exon
induces a frameshift that may result in the introduction of
a PTC that induces degradation of the mRNA by the NMD
mechanism [see examples in (34,35)]. Alternatively, an altern-
ative exon (symmetrical or non-symmetrical) can harbor a
PTC [see examples in (36,37)]. As only 3.4% of the alternative
exons in our dataset encode for a stop codon, we searched
for evidence of PTC generation only as result of frameshifts
Figure 2. Percentage of exons that overlap with protein domain coding sequence. Gray and white indicate the fraction of exons that encodes protein domain
fragmentsorfulldomainsandthosethatdonotencodeforanyfragmentofaproteindomain,respectively.(A)and(B)areforalternativelysplicedexons,(C)and(D)
are for constitutively spliced ones.
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that, we used BLAST to search against GenBank mRNAs for
the exon-including and exon-skipping isoforms of the altern-
ative exons thatareCDS-internal(seeMaterialsandMethods).
We used GenBank mRNAs for this analysis because PTC
+
mRNAs were found to have a low representation in RefSeq,
compared with GenBank (15).
Interestingly, we detected an exon-skipping mRNA for only
42.7% (101/236) of the non-symmetrical exons, compared
with 92.2% (475/515) of the symmetrical exons (exons for
which no skipping mRNA was detected are known to be
alternative based on EST-data solely). Then, for all alternative
exons for which skipping mRNAs were found, we calculated
the inclusion level, which is the fraction of total transcripts of
the gene that includes the exon (see Materials and Methods).
As already mentioned, conserved alternative exons usually
exhibit a high inclusion level (22). However, we found that
the average inclusion level of non-symmetrical exons is sig-
niﬁcantly higher than that of symmetrical exons: 0.74 and
0.59, respectively, P < 1 · 10
 31 (t-test). The low percentage
of non-symmetrical exons with mRNA evidence for their
skipping isoform, along with the high inclusion level of
these exons, shows that the exon-skipping isoforms of
non-symmetrical alternative exons have a very low coverage
among GenBank mRNAs. This may indicate that skipping of a
large fraction of conserved non-symmetrical alternative exons
leads to NMD activation.
Non-symmetrical alternative exons tend to reside near
the ends of the CDS, with a higher preference for
50 locations
As NMD activation depends upon the location of the termina-
tion codon relative to the last exon–exon junction, we wanted
to examine whether non-symmetrical alternative exons tend to
reside in speciﬁc portions of the CDS. For that, we found the
location of all CDS-internalexons in their including mRNAby
normalizing the CDS length between 0 and 1 (see Materials
and Methods), and compared, in increments of 0.1, the per-
centage of symmetrical and non-symmetrical alternative and
constitutive exons at different normalized locations (Figure 4).
We found that non-symmetrical exons exhibit a tendency to
reside in the 50 half of the CDS, with average location of 0.39,
median 0.31 (Figure 4B). There is also a slight rise in the
percentage of non-symmetrical alternative exons toward
the 30 end of the CDS. Symmetrical alternative exons and
Figure 3. Percentage of symmetrical and non-symmetrical exons that encode different fractions of protein domains. (A) The percentage of symmetrical and non-
symmetrical alternative andconstitutiveexonsthat encodefordifferentfragmentsofproteindomains,startingwith exonsnotencodingany domainfragment(0%),
then encoding different sizes of fragments (in increments of 10%) up to encoding complete domains (the bar marked 100%). Statistically significant differences
between symmetrical and non-symmetrical alternative exons and between symmetrical and non-symmetrical constitutive exons are highlighted in gray. (B–E)A
histogram representation of the results shown in (A), indicating the percentage of exons that do not encode protein domains (0%), encodes more than 0% and up to
10%ofproteindomains(>0%,<10%),encodesmedium-sizedfragments(>10%,<60%),encodesfragmentsthatconsistof>60%and<100%ofproteindomainsor
holds complete domains. B and C show the distribution of alternative exons, D and E show that of constitutive exons.
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tions within the CDS: average location of 0.49 and 0.51 for
symmetrical alternative and constitutive exons, respectively
(Figures 4A, C and D). The difference between the average
normalized location of symmetrical and non-symmetrical
alternative exons is statistically signiﬁcant: P < 2.7 · 10
 0.5
(t-test). There is also a slight drop in the percentage of sym-
metrical alternative exons and all constitutive exons near the
ends of the CDS, which may result from a tendency of the start
and stop codons not to lie near exon–exon junctions (as it is
in exons with average normalized location which is between
0 and 0.1 or 0.9 and 1). We also checked whether the 43%
of non-symmetrical alternative exons, which have mRNA
evidence for their skipping, differ from the rest of the non-
symmetrical alternative exons with respect to a preference to
reside in a speciﬁc location along the CDS, but found no such
difference (data not shown).
Analysis of the effect on the reading frame of alternative
splicing events of non-symmetrical exons
Skipping or inserting of cassette exons can be accompanied by
other alternative splicing events (splicing of other exons, use
of alternative initiation or termination, etc.). Careful analysis
of all the differences between the exon-including isoforms
and the exon-skipping ones may require a very sophisticated
computational algorithm. Therefore, we decided to perform
such an analysis manually on a random sample of alternative
exons. For that, we randomly sampled a group of 30 symmet-
rical alternative exons and 30 non-symmetrical ones of the 101
and 475 symmetrical and non-symmetrical exons, respect-
ively, that are CDS-internal and have mRNA evidence in
GenBank for both their inclusion and skipping. For each
of the 60 sampled exons, we used the mRNA/genomic
alignments in the UCSC genome browser (see Materials
and Methods) to compare one of their exon-skipping isoforms
with one of their exon-including isoforms, with regard to
preservation of the reading frame between the two isoforms
and generation of a PTC. Stop codons were considered as
PTCs if they were located more than 55 nt upstream from
the 30-most exon–exon junction (38).
For the 30 non-symmetrical exons, we detected three cat-
egories of differences between the including and skipping
isoforms (Figure 5). For  53% (16/30) of these exons
(category A), the reading frame downstream of the alternative
exon is different in the skipping and including isoforms.
Among these 16 exons, the skipping isoform contains a PTC
in four cases and the including isoform contains a PTC in
two cases. In category B, which contains  37% (11/30) of
the exons, an alternative start codon ensures the use of the
samereadingframedownstreamfromthe alternativeexon(but
introduces a different reading frame upstream to the alternat-
ive exons). Among these 11 exons, the skipping isoform is
PTC
+ in one case. Category C contains three exons for which
the including and skipping isoforms have a different reading
frame (both upstream and downstream from the alternative
exon).Amongthesethreeexons,theskippingisoformcontains
a PTC in one case, and, in another case, the including isoform
is PTC
+. To summarize, in 20% (6/30) of pairs the skipping
isoform was PTC
+; in 10% (3/30), the including isoform was
PTC
+; and, in 70%, none of the isoforms harbored a PTC. For
comparison, none of the skipping or including isoforms of the
30 symmetrical alternative exons meets the deﬁnition of a
PTC
+ mRNA.
We also examined the location in CDS of the alternative
non-symmetrical exons in categories A and B, for which
neither inclusion nor skipping introduces a PTC. For the
10 exons in category A, where both isoforms share the same
reading frame upstream from the alternative exon, the average
normalized location is 0.68 (median 0.76). For the 10 exons in
Figure 4. Percentage of symmetrical and non-symmetrical exons along the CDS. (A–D) Percentage of exons in different locations along the CDS, in increments of
0.1 (exon locations in CDS are normalized between 0 and 1, see Supplementary Data). A and B show the distribution of alternative exons, C and D show that of
constitutive exons.
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downstream from the alternative exon, the average location
is 0.21 (median 0.19). These ﬁndings show that the location of
these alternative non-symmetrical exons ensures that most of
the reading frame remains unchanged in both the skipping
and including isoforms. For comparison, the average normal-
ized location of the 30 symmetrical exons is 0.48 (median
0.49), indicating no preference of these exons for speciﬁc
locations within the CDS.
DISCUSSION
In this report, we found that conserved symmetrical and non-
symmetrical alternative exons differ with respect to several
characteristics. We showed that the tendency of symmetrical
alternative exons to overlap with protein domains is signiﬁc-
antly lower,comparedwith non-symmetrical alternative exons
and all constitutive exons. This low tendency results from
the bias of symmetrical alternative exons not to overlap
with medium-sized fragments (10–60%) of protein domains.
We also showed that non-symmetrical alternative exons tend
to reside in the 50 half of the CDS and have a higher inclusion
level, compared with symmetrical alternative exons. Our ﬁnd-
ings are summarized in Table 1. Supplementary Table 1 shows
that alternative cassette exons in mouse, rat and dog that are
conserved in human possess similar characteristics.
In our dataset, 68.6% of human CDS-internal alternative
exons that are conserved in mouse are symmetrical. Other
Table 1. Differences between symmetrical and non-symmetrical alternative exons and constitutive ones, with respect to several characteristics
Characteristic Alternative exons Constitutive exons
Symmetrical Non-Symmetrical Symmetrical Non-Symmetrical
Percentage of total CDS-internal exons 68.6% 31.4% 40% 60%
Average exon size (nt) 113.3 116.9
a 128.4 131.2
Percentage of exons that overlap with protein-domains
Total
b 30.3% 53% 54% 54.3%
a
Medium-sized
c 15% 39.4% 34.8% 36%
a
Full domain
d 2.3% 0%
a 2.6% 0.06%
Percentage of exons with mRNA evidence of skipping 92.2% 42.7% N/A N/A
Average inclusion level 0.59 0.74 N/A N/A
Average location in RefSeq mRNAs 0.49 0.39 0.51 0.51
a
aDifference did not reach statistical significance.
bPercentage of exons overlapping with protein-domains fragments or complete protein-domains.
cPercentage of exons overlapping with medium-sized fragments (10–60%) of protein-domains.
dPercentage of exons that possess a complete protein-domain.
Figure 5. Differences between the including and skipping isoforms of 30 random non-symmetrical alternative exons. Six different types of pairs of inclusion/
skipping isoforms were grouped into three categories (A–C). In each pair, the upper and lower isoforms represent the including and skipping mRNA, respectively.
Theaccessionnumbersofallinclusion/skippingpairsthatrepresentthiscategoryareindicatedontheright(includingisoform,skippingisoform).Accessionnumbers
ofPTC
+mRNAsareinbold.Openboxesindicatethesamereadingframeforbothisoforms,andboxeswithverticallinesindicatedifferentreadingframes.Theboxes
represent only the CDS portion of the mRNA. In category (A), skipping of the alternative exon induces a frameshift downstream from the exon. In 11 cases, the
including and skipping isoforms have the same start codon (ATG). In five cases, the two isoforms use different ATGs, but the reading frame upstream from the
alternative exon remains the same. In category (B), use of an alternative ATG ensures that both isoforms share the same reading frame downstream from
the alternative exon. In two cases, both ATGs are upstream from the exon, and, thus, the two isoforms have a different reading frame upstream from the exon.
In seven cases, the skipping isoform uses an alternative in-frame ATG downstream from the alternative exon. In the other two cases, an alternative in-frame ATG
upstreamfromtheexonisused,butanalternativesplicingeventdownstreamfromtheexonintroducesadifferentstopcodonattheskippingisoform.Incategory(C),
both isoforms differ in their start and stop codons and do not share the same reading frame throughout the CDS.
5580 Nucleic Acids Research, 2005, Vol. 33, No. 17studies reported varying percentages of symmetrical exons
among conserved CDS-internal alternative exons, ranging
from 53 to 77% (19,25,26). However, as conserved CDS-
internal alternative exons show a strong bias to be symmetrical
in all studies, these discrepancies probably result from differ-
ences in dataset compilation and do not reﬂect meaningful
contradictions between the different works.
It has been previously reported that the borders of altern-
ative exons tend to correlate with protein domain borders,
probably to eliminate potentially deleterious splice variants
that contain broken domains (39). The observed bias of sym-
metrical alternative exons not to overlap with medium-sized
fragmentsof protein domainsshows that this tendency ismuch
stronger among symmetrical alternative exons. This bias
may reﬂect a negative selection on symmetrical exons that
produce transcripts with broken domains. Non-symmetrical
alternative exons show the same pattern of overlapping
with different fractions of domains as do constitutive exons,
which may indicate that non-symmetrical alternative exons
are indifferent to this selection pressure.
As inclusion or skipping of symmetrical exons does not
alter the mRNA’s reading frame, it would be reasonable to
hypothesize that, compared with non-symmetrical ones, these
exons would be more prone to play the role of domain-holders
(i.e. alternative exons that encode large fragments of
domains and thus their skipping eliminates the domain func-
tionality). We did ﬁnd that among exons that encode >60% of
protein domains, symmetrical alternative exons have a slightly
higher representation, but this result did not reach statistical
signiﬁcance. Skipping of exons that encode >60% of protein
domains is very likely to eliminate the functionality of the
domains with which these exons overlap. Therefore, such
exons probably act as domain-holders. However, our ﬁndings
suggest that only a small fraction (<4%) of alternative exons
are domain-holders. This indicates that selective removal or
insertion of protein domains (at least of the type represented in
Pfam and SMART databases) into different splice forms is not
a major role of alternative splicing. We also found that the
ratio of symmetrical and non-symmetrical alternative exons
that encode such large fragments of protein domains is similar
to that of symmetrical and non-symmetrical constitutive
exons. This may indicate that the tendency of alternative
exons to be domain-holders is not higher than expected by
chance.
We also found that mRNAs representing the skipping of
non-symmetrical alternative exons are strongly underrepres-
ented in GenBank, compared with those of symmetrical
alternative exons. It has already been suggested that
mRNAs subjected to NMD have a low coverage in databases
because of their rapid degradation (15). Therefore, it is pos-
siblethatalargefraction oftheexon-skippingisoforms ofnon-
symmetrical exons underwent NMD degradation, and, thus,
these isoforms are not detected. The ﬁnding that non-
symmetrical alternative exons tend to reside in the 50 half
of the CDS (average normalized location of half of them is
lower than 0.31) can also be related to NMD activation.
Reasonably, skipping of non-symmetrical exons from more
upstreamlocations, notaccompanied with use ofanalternative
in-frame start codon, has a higher potential to introduce a stop
codon in the frameshift induced downstream from the skipped
exon. Also, PTCs closer to the 50 end may trigger more robust
NMD, as in the case of the TCR-b gene (40). Therefore, it is
possible that skipping events of non-symmetrical exons are
preserved in evolution for NMD activation, which may be
more effective if they are skipped from locations within the
50 half of the CDS.
However, there is also an increase in the representation of
non-symmetrical alternative exons near the 30 end of the CDS.
This increase was observed for both non-symmetrical exons
with mRNA evidence for their skipping isoforms and those
without such evidence. A manual inspection of the effects
on the reading frame of 30 random splicing events of non-
symmetrical alternative exons suggests that non-symmetrical
alternative exons that do not generate PTC
+ mRNAs tend to
reside near the ends of the CDS, and this allows the including
and skipping isoforms to use the same reading frame through-
out most of the CDS. In half of such cases in our sample, the
exons resided in proximity to the 50 end of the CDS and the
including and skipping isoforms used a different ATG. This
allowed the preservation of the reading frame downstream
from the exon. Elimination of an otherwise potent PTC by
means of alternative initiation has already been reported in the
case of the b-globin and TPI genes (41,42). In the other cases,
the exons were found to reside in proximity to the 30 end of the
CDS, and, as a result, the frameshift they induced was short
and did not harbor a PTC. This also allowed the preservation
of most of the reading frames in both the including and skipp-
ing isoforms.
The low coverage of the skipping isoforms of non-
symmetrical alternative exons, along with the fact that,
in 2/3 of alternative splicing events that generated PTCs in
our random sample, the skipping isoform was the PTC
+,
suggests that the most prevalent mechanism for the generation
of a PTC is skipping of a non-symmetrical exon. As only
 3% of alternative exons in our dataset encode for a stop
codon, it is likely that creation of a stop codon by means
of insertion of a cassette exon that harbors a PTC is a
much less-used mechanism for NMD activation. Moreover,
as our ﬁndings suggest that the including isoform of many
non-symmetrical alternative exons is being translated into pro-
tein and that the skipping isoforms undergoes NMD degrada-
tion, it is likely that the including isoform of these exons
represents the ancestral state of these exons. This supports
a hypothesis we recently suggested that constitutively
spliced exons can switch to alternative splicing in the course
of evolution (21). The average high inclusion level of all
conserved alternative exons and the tendency of these
exons not to contain repetitive elements further support this
idea. According to this model, the selection against transition
of non-symmetrical constitutive exons to alternative splicing
is weaker near the CDS ends, because skipping these exons
either preserves most of the reading frames in the skipping
isoform (as described above) or can be used for the generation
of NMD-targeted transcripts that may play a regulatory role.
Transition of symmetrical exons from constitutive to altern-
ative splicing is probably under negative selection if these
exons encode for medium-sized fragments of protein domains.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5581ACKNOWLEDGEMENTS
The authors thank David Haussler, Chuck W Sugnet, Ido
Carmel, Rotem Sorek and Amir Goren for sharing datasets,
and Rotem Sorek for helpful discussion. This work was sup-
ported by a grant from the Israel Science Foundation (1449/04
and 40/05) and, in part, by a grant from the German Israeli
Project Cooperation Program, German Israeli R&D, and the
Chief ScientistoftheIsraelHealthMinistrytoG.A.Fundingto
pay the Open Access publication charges for this article was
provided by German Israeli Research and Development.
Conflict of interest statement. None declared.
REFERENCES
1. Lareau,L.F., Green,R.E., Bhatnagar,R.S. and Brenner,S.E. (2004)
The evolving roles of alternative splicing. Curr. Opin. Struct. Biol.,
14, 273–282.
2. Lee,C. and Wang,Q. (2005) Bioinformatics analysis of alternative
splicing. Brief Bioinformatics, 6, 23–33.
3. Woodley,L.andValcarcel,J.(2002)Regulationofalternativepre-mRNA
splicing. Brief Funct. Genomic. Proteomic, 1, 266–277.
4. Modrek,B. and Lee,C. (2002) A genomic view of alternative splicing.
Nature Genet., 30, 13–19.
5. Leipzig,J., Pevzner,P. and Heber,S. (2004) The alternative splicing
gallery (ASG): bridging the gap between genome and transcriptome.
Nucleic Acids Res., 32, 3977–3983.
6. Schmucker,D., Clemens,J.C., Shu,H., Worby,C.A., Xiao,J., Muda,M.,
Dixon,J.E. and Zipursky,S.L. (2000) Drosophila Dscam is an axon
guidance receptor exhibiting extraordinary molecular diversity.
Cell, 101, 671–684.
7. Cline,M.S., Shigeta,R., Wheeler,R.L., Siani-Rose,M.A., Kulp,D. and
Loraine,A.E.(2004)Theeffectsofalternativesplicingontransmembrane
proteins in the mouse genome. Pac. Symp. Biocomput., 17–28.
8. Grabowski,P.J. and Black,D.L. (2001) Alternative RNA splicing in the
nervous system. Prog. Neurobiol., 65, 289–308.
9. Copley,R.R. (2004) Evolutionary convergence of alternative splicing in
ion channels. Trends Genet, 20, 171–176.
10. Bassett,C.L., Artlip,T.S. and Callahan,A.M. (2002) Characterization of
the peach homologue of the ethylene receptor, PpETR1, reveals some
unusual features regarding transcript processing. Planta, 215, 679–688.
11. Hillman,R.T., Green,R.E. and Brenner,S.E. (2004) An unappreciated
role for RNA surveillance. Genome Biol., 5, R8.
12. Holbrook,J.A., Neu-Yilik,G., Hentze,M.W. and Kulozik,A.E. (2004)
Nonsense-mediated decay approaches the clinic. Nature Genet.,
36, 801–808.
13. Frischmeyer,P.A. and Dietz,H.C. (1999) Nonsense-mediated mRNA
decay in health and disease. Hum. Mol. Genet., 8, 1893–1900.
14. Maquat,L.E. (2004) Nonsense-mediated mRNA decay: splicing,
translation and mRNP dynamics. Nature Rev. Mol. Cell Biol., 5, 89–99.
15. Lewis,B.P., Green,R.E. and Brenner,S.E. (2003) Evidence for the
widespread coupling of alternative splicing and nonsense-mediated
mRNA decay in humans. Proc. Natl Acad. Sci. USA, 100, 189–192.
16. Graveley,B.R. (2001) Alternative splicing: increasing diversity in the
proteomic world. Trends Genet., 17, 100–107.
17. Maniatis,T. and Tasic,B. (2002) Alternative pre-mRNA splicing and
proteome expansion in metazoans. Nature, 418, 236–243.
18. Baranova,A.V., Lobashev,A.V., Ivanov,D.V., Krukovskaya,L.L.,
Yankovsky,N.K. and Kozlov,A.P. (2001) In silico screening for
tumour-specific expressed sequences in human genome. FEBS Lett.,
508, 143–148.
19. Sorek,R., Shamir,R. and Ast,G. (2004) How prevalent is functional
alternative splicing in the human genome? Trends Genet., 20, 68–71.
20. Xu,Q. and Lee,C. (2003) Discovery of novel splice forms and functional
analysis of cancer-specific alternative splicing in human expressed
sequences. Nucleic Acids Res., 31, 5635–5643.
21. Ast,G. (2004) How did alternative splicing evolve? Nature Rev. Genet.,
5, 773–782.
22. Modrek,B. and Lee,C.J. (2003) Alternative splicing in the human,
mouse and rat genomes is associated with an increased frequency of
exon creation and/or loss. Nature Genet., 34, 177–180.
23. Kaessmann,H., Zollner,S., Nekrutenko,A. and Li,W.H. (2002)
Signatures of domain shuffling in the human genome. Genome Res., 12,
1642–1650.
24. Philipps,D.L., Park,J.W. and Graveley,B.R. (2004) A computational and
experimental approach toward a priori identification of alternatively
spliced exons. RNA, 10, 1838–1844.
25. Resch,A., Xing,Y., Alekseyenko,A., Modrek,B. and Lee,C. (2004)
Evidence for a subpopulation of conserved alternative splicing events
under selection pressure for protein reading frame preservation.
Nucleic Acids Res., 32, 1261–1269.
26. Baek,D. and Green,P. (2005) Sequence conservation, relative isoform
frequencies, and nonsense-mediated decay in evolutionarily conserved
alternative splicing. Proc. Natl Acad. Sci. USA, 102, 12813–12818.
27. Liu,M. and Grigoriev,A. (2004) Protein domains correlate strongly with
exons in multiple eukaryotic genomes—evidence of exon shuffling?
Trends Genet., 20, 399–403.
28. Pruitt,K.D., Tatusova,T. and Maglott,D.R. (2005) NCBI Reference
Sequence (RefSeq): a curated non-redundant sequence database of
genomes, transcripts and proteins. Nucleic Acids Res., 33, D501–D504.
29. Carmel,I., Tal,S., Vig,I. and Ast,G. (2004) Comparative analysis detects
dependencies among the 50 splice-site positions. RNA, 10, 828–840.
30. Sugnet,C.W., Kent,W.J., Ares,M.,Jr and Haussler,D. (2004)
Transcriptome and genome conservation of alternative splicing events
in humans and mice. Pac. Symp. Biocomput., 66–77.
31. Bateman,A., Birney,E., Durbin,R., Eddy,S.R., Howe,K.L. and
Sonnhammer,E.L. (2000) The Pfam protein families database.
Nucleic Acids Res., 28, 263–266.
32. Letunic,I., Copley,R.R., Schmidt,S., Ciccarelli,F.D., Doerks,T.,
Schultz,J., Ponting,C.P. and Bork,P. (2004) SMART 4.0: towards
genomic data integration. Nucleic Acids Res., 32, D142–D144.
33. Sorek,R., Shemesh,R., Cohen,Y., Basechess,O., Ast,G. and Shamir,R.
(2004) A non-EST-based method for exon-skipping prediction.
Genome Res., 14, 1617–1623.
34. Jones,R.B., Wang,F., Luo,Y., Yu,C., Jin,C., Suzuki,T., Kan,M. and
McKeehan,W.L. (2001) The nonsense-mediated decay pathway and
mutually exclusive expression of alternatively spliced FGFR2IIIb
and -IIIc mRNAs. J. Biol. Chem., 276, 4158–4167.
35. Wollerton,M.C., Gooding,C., Wagner,E.J., Garcia-Blanco,M.A. and
Smith,C.W. (2004) Autoregulation of polypyrimidine tract binding
protein by alternative splicing leading to nonsense-mediated decay.
Mol. Cell, 13, 91–100.
36. Winter,J., Lehmann,T., Krauss,S., Trockenbacher,A., Kijas,Z.,
Foerster,J., Suckow,V., Yaspo,M.L., Kulozik,A., Kalscheuer,V. et al.
(2004) Regulation of the MID1 protein function is fine-tuned by a
complex pattern of alternative splicing. Hum. Genet., 114, 541–552.
37. Mitrovich,Q.M. and Anderson,P. (2000) Unproductively spliced
ribosomal protein mRNAs are natural targets of mRNA surveillance in
C.elegans. Genes Dev., 14, 2173–2184.
38. Nagy,E. and Maquat,L.E. (1998) A rule for termination-codon position
within intron-containing genes: when nonsense affects RNA abundance.
Trends Biochem. Sci., 23, 198–199.
39. Kriventseva,E.V., Koch,I., Apweiler,R., Vingron,M., Bork,P.,
Gelfand,M.S. and Sunyaev,S. (2003) Increase of functional diversity
by alternative splicing. Trends Genet., 19, 124–128.
40. Wang,J., Gudikote,J.P., Olivas,O.R. and Wilkinson,M.F. (2002)
Boundary-independent polar nonsense-mediated decay. EMBO Rep.,
3, 274–279.
41. Zhang,J. and Maquat,L.E. (1997) Evidence that translation reinitiation
abrogates nonsense-mediated mRNA decay in mammalian cells.
EMBO J., 16, 826–833.
42. Inacio,A., Silva,A.L., Pinto,J., Ji,X., Morgado,A., Almeida,F.,
Faustino,P., Lavinha,J., Liebhaber,S.A. and Romao,L. (2004)
Nonsense mutations in close proximity to the initiation codon fail to
trigger full nonsense-mediated mRNA decay. J. Biol. Chem., 279,
32170–32180.
5582 Nucleic Acids Research, 2005, Vol. 33, No. 17